Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2007
11/07/2007EP1161687B1 Grb7 family proteins and the insulin receptor for screening novel medicines.
11/07/2007EP1042288B1 Tripeptidyl peptidase inhibitors
11/07/2007EP0833624B1 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
11/07/2007CN101068827A Polymorphs of sarsasapogenin
11/07/2007CN101068823A Tetrahydropyrane derivatives for use as antidiabetics
11/07/2007CN101068779A 9,10-secopregnane derivative and medicine
11/07/2007CN101068769A Arakyl amine vanadium (v) salt for treating or/and preventing diabetic
11/07/2007CN101068556A Pilose antler nano-products containing enriched insulin-like growth factor and producing method thereof
11/07/2007CN101068543A Use of substituted cyclopropane acid derivative in treating metabolic syndrome medicine
11/07/2007CN101068542A Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by anti-retroviral treatment of HIV-infected patients
11/07/2007CN101068541A Method of using punicic acid to enhance immune response and prevent metabolic disorders
11/07/2007CN101068535A Oral compositions for absorption of phosphorus compounds
11/07/2007CN101068472A Modified coffee, method of roasting coffee bean, coffee-like supplement and auxiliary food
11/07/2007CN101066997A Human antibodies that bind human IL-12 and methods for producing
11/07/2007CN101066932A New conjugate linoleic acid derivative and its prepn and use
11/07/2007CN101066407A Chinese medicine capsule for treating hyperlipemia
11/07/2007CN101066323A Sanhuang heat clearing away cold decoction
11/07/2007CN101066316A Composite litchi-male silk moth nutrient liquid and its prepn
11/07/2007CN101066299A Extracting process and product of tartary buckwheat extract with rich tartary buckwheat flavone
11/07/2007CN101066276A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/07/2007CN101066275A Mangiferin-berberine composition
11/07/2007CN101066259A Solid dispersion of higher fatty alcohol and its prepn
11/07/2007CN101066258A Inclusion compound of higher fatty alcohol and its prepn
11/07/2007CN101066151A Beverage for diabetics and its prepn process
11/07/2007CN101066131A Health food assisting blood fat reduction and its production process
11/07/2007CN101066124A Coca-cola produced with natural Chinese herbal medicine
11/07/2007CN101066122A Liquid detergent
11/07/2007CN101066094A Recipe of mixed concentrated feed with bovine gastrin
11/07/2007CN101066083A Health tea of aizoon stonecrop herb
11/07/2007CN101066079A Highland barley tea and its making process
11/07/2007CN100347170C Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
11/07/2007CN100347169C 喹唑啉衍生物 Quinazoline derivatives
11/07/2007CN100347158C Bicyclic compound
11/07/2007CN100347152C Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
11/07/2007CN100346823C Enamel matrix protein compositions for modulating immune response
11/07/2007CN100346805C Application of shinyleaf yellowhorn fruit shell in preparing cerbral function improving food and medicine
11/07/2007CN100346782C Vitamin C composition containing amino acids
11/07/2007CN100346780C Compound preparation for prevention and treatment adiposis and its prepn. method
11/06/2007USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007US7291740 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Mesylate salt
11/06/2007US7291734 N-(4,5,6,7-Tetrahydro-thiazolo[5,4-c]pyridin-2-yl)sulfonamides, e.g., 2-[2-(3,5-Bis-trifluoromethyl-benzenesulfonylamino)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]-4-trifluoromethyl-benzamide; steroid sulfatase inhibitors used to treat diseases including acne
11/06/2007US7291709 LSR (Lipolysis Stimulated Receptor); for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension
11/06/2007US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007US7291635 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
11/06/2007US7291633 nicotinic alpha 7 receptor and 5-HT3 or 5-HT6 receptor; control of cholinergic and dopaminergic neurotransmission; disorders of the central nervous system and serotonergic hyperactivity; psychiatric and neurodegenerativce disorders; antiemetics during chemotherapy
11/06/2007US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases
11/06/2007US7291619 Melanocortin receptor agonists
11/06/2007US7291594 Human glucagon-like peptide-1 (GLP-1) derivatives absorbed highly via a mucous membrane in the oral cavity, lung, nose or intestines; for therapy of non-insulin dependent diabetes muellitus, insulin dependent diabetes mellitus and/or obesity
11/06/2007US7291458 Leptin-mediated gene-induction
11/06/2007US7291451 Modulation of pericyte proliferation
11/06/2007US7291347 Solubility, permeability, and bioavailability; oral dosage
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007CA2388564C Caspase inhibitor
11/06/2007CA2170236C Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
11/02/2007CA2587002A1 Stem cells derived from bone marrow for tissue regeneration
11/01/2007WO2007124337A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007124329A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007124086A1 Induction of weight loss and the selective inhibition of ptp1b
11/01/2007WO2007124045A2 Piperidine and piperazine compounds for use in the treatment of obesity, eating disorders and sexual dysfunction by potentiation of mc4 receptor activity
11/01/2007WO2007124005A2 Methods for treating bone associated diseases by the use of methionine aminopeptidase-2 inhibitors
11/01/2007WO2007123581A1 Glucagon receptor antagonists, preparation and therapeutic uses
11/01/2007WO2007123225A1 Oxadiazolidinedione compound
11/01/2007WO2007123200A1 Composition containing peptide as the active ingredient
11/01/2007WO2007123010A1 Agent for improving bone metabolism
11/01/2007WO2007122970A1 Ligand capable of binding to nuclear receptor
11/01/2007WO2007122885A1 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
11/01/2007WO2007122411A1 Diazepan-1-yl-sulfonyl derivatives for the treatment of metabolic syndrome
11/01/2007WO2007122382A2 Lycopene for the treatment of metabolic dysfunction
11/01/2007WO2007121687A1 4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament
11/01/2007WO2007121584A1 Food product containing policosanols
11/01/2007WO2007121546A1 Use of mas-g-protein-coupled receptor agonists in the treatment of the metabolic syndrome, its components and its complications
11/01/2007WO2007104053A3 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders
11/01/2007WO2007093880A3 Novel pyrone-indole derivatives and process for their preparation
11/01/2007WO2007092416A3 Melanin concentrating hormone receptor-1 antagonists
11/01/2007WO2007092379A3 Sesamol derivatives as novel inhibitors of arachidonic acid formation
11/01/2007WO2007085775A3 Use of 15-lipoxygenase inhibitors for treating obesity
11/01/2007WO2007081755A3 Indole-benzimidazole and indazole inhibitors of tyrosine phosphatases
11/01/2007WO2007079239A3 Bicyclic nitrogen compounds as modulators of ghrelin receptor and uses thereof
11/01/2007WO2007071012A8 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor
11/01/2007WO2007066192A3 Method for weight reduction
11/01/2007WO2007061923A3 Glucokinase activators
11/01/2007WO2007057768A3 Sulfonyl derivatives
11/01/2007WO2006131326B1 Novel use of (-)-epigallocatechin gallate
11/01/2007WO2006097460A8 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
11/01/2007WO2006092507A8 1,2,4-triazine derivatives, preparation and use thereof in human therapy
11/01/2007US20070255062 Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) Activators
11/01/2007US20070254948 Lipase Inhibitors
11/01/2007US20070254944 Metformin and a dipeptidyl peptidase IV inhibitor such as vildagliptin; improving glucose control
11/01/2007US20070254931 Thiazole Derivatives Having Vap-1 Inhibitory Activity
11/01/2007US20070254919 Aroyl-O-Piperidine Derivatives for the Treatment of Diabetes-Related Problems
11/01/2007US20070254917 Intracellular receptor modulator compounds and methods
11/01/2007US20070254908 7-azaindoles, pharmaceutical compositions and their therapeutic applications
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254866 Aminoquinolones as GSK-3 inhibitors
11/01/2007US20070254865 Aminocyclohexanes as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
11/01/2007US20070254857 2Alpha-Methyl-19-Nor-(20S)-1Alpha-Hydroxy-Bishomopregnacalciferol and Its Uses
11/01/2007US20070254848 Algin Oligosaccharides and the Derivatives thereof as Well as the Manufacture and the Use of the Same
11/01/2007US20070254838 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
11/01/2007US20070254053 lowering blood sugar by administering extracts of Costus pictus to mammals having hyperglycemia
1 ... 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 ... 1298